October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Chris Cutie on the latest episode of the Uromigos podcast
Oct 21, 2024, 15:05

Chris Cutie on the latest episode of the Uromigos podcast

Uromigos shared a post on X:

“In our latest podcast episode, Dr. Chris Cutie of Johnson and Johnson Innovation covers many questions about the gemcitabine-eluting pretzel, like its origin, catheter changes, assessing toxicity, the SunRISe series, and TAR-200 combo agents.”

Listen here.

Chris Cutie

Christopher Cutie is the Vice President and Disease Area Leader of Bladder Cancer at The Janssen Pharmaceutical Companies of Johnson & Johnson. He also co – founded Jointpoint and was the chief medical officer at TARIS Bio (acquired by Janssen Oncology).